News Archive

From our involvement in the Human Genome Project, to our efforts to understand the genetic basis of disease, we have been involved in some of the most important discoveries of the 20th and 21st Centuries.

Learn more by browsing Sanger Institute news stories, press releases and features to date.

Dr Jeffrey Barrett to lead Centre for Therapeutic Target Validation

Dr Jeffrey Barrett to lead Centre for Therapeutic Target Validation27.02.15: Sanger Institute, EMBL-EBI, and GSK initiative selects founding Director

more

Leukaemia-associated mutations almost inevitable as we age

Leukaemia-associated mutations almost inevitable as we age26.02.15: Researchers estimate that 7 in 10 over 90-year-olds harbour cells with early leukaemia mutations

more

CRISPR collaboration aims to speed drug discovery

CRISPR collaboration aims to speed drug discovery29.01.15: Sanger Institute to share genome-editing expertise with AstraZeneca

more

American Society of Clinical Oncology highlights Sanger Institute research

American Society of Clinical Oncology highlights Sanger Institute research20.01.15: Study into the origins of cancer included in prestigious annual report

more

Genetics underpinning antimalarial drug resistance revealed

Genetics underpinning antimalarial drug resistance revealed19.01.15: Largest genome-wide study of parasite provides clearest picture yet of genetic changes driving artemisinin resistance

more

Novel breast cancer gene found

Novel breast cancer gene found09.01.15: The BCL11A gene has been identified as being especially active in aggressive subtypes of difficult-to-treat breast cancer.

more

Contact the Press Office

Don Powell Media and Public Relations Manager
Wellcome Trust Sanger Institute, Hinxton, Cambs, CB10 1SA, UK

Tel +44 (0)1223 496 928
Mobile +44 (0)7753 775 397
Fax +44 (0)1223 494 919
Email press.office@sanger.ac.uk

* quick link - http://q.sanger.ac.uk/kwuhwgt1